Remarkable advances have occurred since the Series 3 Fascicle published in 1995 with paradigm shifts in every dimension of our understanding of lung tumors including clinical, radiologic, histopathologic, cytopathologic, immunohistochemical, molecular and therapeutic aspects. The molecular revolution leading to effective targeted therapies and breakthroughs in immunotherapy for lung cancer have led to novel approaches incorporating the concept of personalized medicine for patients who historically had little hope. These advances have strengthened the place of pathologists to play a central role in the multidisciplinary team that is now needed to properly diagnose and manage lung cancer patients.

This title is the first prize winner at the 2006 BMA Medical Book Awards. With an emphasis on practical diagnostic problem solving, this New Edition provides readers with an accessible, comprehensive guide to the recognition and interpretation of neoplastic and non-neoplastic lung disorders. The text is lavishly illustrated with more than 989 high quality illustrations - more than 889 in full color - that accurately depict the histologic and cytologic findings under consideration. Readers will also find useful tips and advice from two internationally respected experts, as well as a user-friendly design and format that allow rapid access to essential information. The incorporation of relevant clinical and radiographic information renders this reference a complete diagnostic resource inside the reporting room.